Neuroone Medical Technologies NMTC
NASDAQ NMTC
$2.30 +0.12 (+5.31%)
At close: Aug 20, 2026 · 11:58 AM UTC

Neuroone Medical Technologies (NMTC) Raw Materials (2023)

Neuroone Medical Technologies' (NMTC) quarterly Raw Materials came in at $1.0 million in Q4 2023, down 13.21% on a QoQ basis from $1.2 million in Q3 2023.

Neuroone Medical Technologies (NMTC) Raw Materials (2023) Analysis & Trends

Neuroone Medical Technologies (NMTC) has 1 years of Raw Materials data on file, last reported at $1.0 million in Q4 2023.

  • Quarterly Raw Materials changed N/A year-over-year to $1.0 million in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $1.0 million (changed N/A YoY) and the FY2023 annual result came in at $1.2 million, changed N/A from the prior year.
  • Raw Materials eased to $1.0 million in Q4 2023, from $1.2 million in the prior quarter.
  • In the past five years, Raw Materials ranged from a high of $1.2 million in Q3 2023 to a low of $1.0 million in Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 200.19 Bn 194.59 Bn 7.27 Bn
2 Stryker 129.95 Bn 126.47 Bn 4.50 Bn
3 Medtronic 120.06 Bn 110.84 Bn 6.41 Bn
4 Boston Scientific 74.14 Bn 73.60 Bn 3.85 Bn
5 Edwards Lifesciences 52.74 Bn 48.49 Bn 1.35 Bn
6 Dexcom 34.60 Bn 32.65 Bn 830.00 Mn
7 GE HealthCare Technologies 34.20 Bn 32.10 Bn 2.18 Bn
8 Koninklijke Philips 26.46 Bn 23.13 Bn 4.55 Bn
9 Steris 23.25 Bn 22.77 Bn 684.20 Mn
10 Neuroone Medical Technologies 19.89 Mn 17.84 Mn 1.18 Mn

Historic Data

Download Data
DateValue
Dec 31, 2023 1.04 Mn
Sep 30, 2023 1.20 Mn